Translational Medicine Center, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, China.
Department of Nutrition, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
J Nutr. 2023 Aug;153(8):2442-2452. doi: 10.1016/j.tjnut.2023.06.036. Epub 2023 Jun 28.
The effect of iron supplementation during pregnancy on birth outcomes may vary with maternal genetic background and needs more investigation.
This prospective study aimed to evaluate the interactions between maternal iron supplementation and iron metabolism-related genetic polymorphisms on birth outcomes.
This was a substudy from a community-based randomized control trial conducted in Northwest China, which included 860 women from the 2 micronutrient supplementation groups (folic acid [FA] and FA + iron group). Maternal peripheral blood, sociodemographic and health-related information, and neonatal birth outcomes were collected. Six single nucleotide polymorphisms in iron metabolism-related genes were genotyped. The alleles associated with decreased iron/hemoglobin status were used as the effect alleles. The genetic risk score (GRS) that reflected the genetic risk of low iron/hemoglobin status was estimated using the unweighted and weighted methods. Generalized estimating equations with small-sample corrections were applied to evaluate the interactions between iron supplementation and SNPs/GRS on birth outcomes.
There were significant interactions between maternal iron supplementation and rs7385804 (P = 0.009), rs149411 (P = 0.035), rs4820268 (P = 0.031), the unweighted GRS (P = 0.018), and the weighted GRS (P = 0.009) on birth weight. Compared with FA supplementation only, FA + iron supplementation significantly increased birth weight among women with more effect alleles in rs7385804 (β: 88.8 g, 95% CI: 9.2, 168.3) and the GRSs (the highest unweighted GRS, β: 135.5 g, 95% CI: 7.7, 263.4; the highest weighted GRS, β: 145.9 g, 95% CI: 43.4, 248.5); it had a trend of decreasing birth weight and increasing low birth weight risk among women with fewer effect alleles.
In our population, maternal genetic background related to iron metabolism plays a significant role in determining the efficacy of iron supplementation. Routine iron supplementation could be more beneficial to fetal weight growth among mothers with higher genetic risk for low iron/hemoglobin status.
孕期补铁对出生结局的影响可能因母体遗传背景和需求而异,需要更多的研究。
本前瞻性研究旨在评估母体补铁与铁代谢相关遗传多态性之间的相互作用对出生结局的影响。
这是在中国西北地区进行的一项基于社区的随机对照试验的子研究,纳入了来自 2 个微量营养素补充组(叶酸[FA]和 FA+铁组)的 860 名女性。采集了母体外周血、社会人口学和健康相关信息以及新生儿出生结局。对铁代谢相关基因的 6 个单核苷酸多态性进行了基因分型。将与铁/血红蛋白状态降低相关的等位基因用作效应等位基因。使用无权重和权重方法估计反映铁/血红蛋白状态低遗传风险的遗传风险评分(GRS)。采用小样本校正的广义估计方程评估铁补充与 SNPs/GRS 对出生结局的相互作用。
母体铁补充与 rs7385804(P=0.009)、rs149411(P=0.035)、rs4820268(P=0.031)、无权重 GRS(P=0.018)和权重 GRS(P=0.009)之间存在显著的相互作用,对出生体重有影响。与仅补充 FA 相比,FA+铁补充在 rs7385804 中具有更多效应等位基因的女性(β:88.8 g,95%CI:9.2,168.3)和 GRSs(最高无权重 GRS,β:135.5 g,95%CI:7.7,263.4;最高权重 GRS,β:145.9 g,95%CI:43.4,248.5)中,出生体重显著增加;而在具有较少效应等位基因的女性中,出生体重呈下降趋势,低出生体重风险增加。
在本研究人群中,铁代谢相关的母体遗传背景在确定铁补充的疗效方面起着重要作用。对于铁/血红蛋白状态遗传风险较高的母亲,常规铁补充可能更有利于胎儿体重增长。